跳至主要内容
临床试验/NCT01334957
NCT01334957已完成4 期

A Multi-Center, Open-Label, Surgical Surveillance Trial To Evaluate The Safety And Efficacy Of A Shortened Infusion Time of Intravenous Ibuprofen

Cumberland Pharmaceuticals22 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2011年6月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
300
试验地点
22
主要终点
To Determine the Safety of a Single Dose of Intravenous Ibuprofen Over 5-10 Minutes for the Reduction of Pain.

研究概览

简要总结

The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the preemptive treatment of postoperative pain.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for surgery with anticipated need for postoperative analgesia

排除标准

  • Patients with inadequate IV access
  • Patients <18 years of age
  • History or allergy or hypersensitivity to any component of intravenous ibuprofen, aspirin (or aspirin related products) or non-steroidal anti-inflammatory drug (NSAIDs)
  • Active hemorrhage or clinically significant bleeding
  • Pregnant or nursing
  • Patients in the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery
  • Inability to understand the requirements of the study, be willing to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board [IRB]), and agree to abide by the study restrictions
  • Refusal to provide written authorization for use and disclosure of protected health information

研究组 & 干预措施

Intravenous ibuprofen

Experimental

Intravenous ibuprofen (800 mg intravenous ibuprofen administered intravenously over 5-10 minutes) will be administered as a single dose during the 10 minute Treatment Period.

干预措施: Intravenous ibuprofen (Drug)

结局指标

主要结局

To Determine the Safety of a Single Dose of Intravenous Ibuprofen Over 5-10 Minutes for the Reduction of Pain.

时间窗: 6 hours

The incidence of treatment-emergent serious adverse events occurring in the six hours following administration of the first dose of intravenous ibuprofen

To Determine the Safety of a Single Dose of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Reduction of Post-operative Pain.

时间窗: 6 hours

The incidence of treatment-emergent adverse events occurring in the six hours following administration of the first dose of intravenous ibuprofen

次要结局

  • To Determine the Safety of a Multiple Doses of Intravenous Ibuprofen Over 5-10 Minutes for the Reduction of Pain.(6 hours)
  • To Determine the Safety of a Multiple Doses of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Reduction of Post-operative Pain.(6 hours)

研究者

发起方
Cumberland Pharmaceuticals
申办方类型
Industry
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验